Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Obese and lean women with PCOS have different symptoms and need different treatments.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Fenugreek seeds help with diabetes and cholesterol, while leaves fight microbes and dandruff.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Many female medical students in Saudi Arabia show signs of insulin resistance linked to increased waist size.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

No cure for female pattern hair loss, but various effective treatments exist.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.